Microfluidic Systems is Awarded New Patents in the Area of Automated Biological Agent Identification

Microfluidic Systems (MFSI), a privately-held company, announced today that it has been awarded a series of patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins.

Related Posts

Comments are closed.